Industry: Service & Software
Published Date: 2024-05-21
Pages: 107 Pages
Report ld: 3158175
Request Sample
Customized Report
The global Gene Site-Directed Mutagenesis Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Gene Site-Directed Mutagenesis Services revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Gene Site-Directed Mutagenesis Services market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Gene Site-Directed Mutagenesis Services include ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, etc. The global five biggest players hold a share of % in 2023.
Global Gene Site-Directed Mutagenesis Services Scope and Market Size
Gene Site-Directed Mutagenesis Services market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Gene Site-Directed Mutagenesis Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Gene Site-Directed Mutagenesis Services market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Gene Site-Directed Mutagenesis Services definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Gene Site-Directed Mutagenesis Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Gene Site-Directed Mutagenesis Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Site-Directed Mutagenesis Services revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Gene Site-Directed Mutagenesis Services Product Introduction
1.2 Global Gene Site-Directed Mutagenesis Services Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Gene Site-Directed Mutagenesis Services Market Size for the Year 2019-2030
1.2.2 United States Gene Site-Directed Mutagenesis Services Market Size for the Year 2019-2030
1.3 Gene Site-Directed Mutagenesis Services Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Gene Site-Directed Mutagenesis Services in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Gene Site-Directed Mutagenesis Services Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Gene Site-Directed Mutagenesis Services Market Dynamics
1.4.1 Gene Site-Directed Mutagenesis Services Industry Trends
1.4.2 Gene Site-Directed Mutagenesis Services Market Drivers
1.4.3 Gene Site-Directed Mutagenesis Services Market Challenges
1.4.4 Gene Site-Directed Mutagenesis Services Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Gene Site-Directed Mutagenesis Services by Type
2.1 Gene Site-Directed Mutagenesis Services Market by Type
2.1.1 Synonymous Mutations
2.1.2 Missense Mutation
2.1.3 Nonsense Mutation
2.2 Global Gene Site-Directed Mutagenesis Services Market Size by Type (2019, 2023 & 2030)
2.3 Global Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2030)
2.4 United States Gene Site-Directed Mutagenesis Services Market Size by Type (2019, 2023 & 2030)
2.5 United States Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2030)
3 Gene Site-Directed Mutagenesis Services by Application
3.1 Gene Site-Directed Mutagenesis Services Market by Application
3.1.1 Medical Industry
3.1.2 Biological Research
3.1.3 Others
3.2 Global Gene Site-Directed Mutagenesis Services Market Size, by Application (2019, 2023 & 2030)
3.3 Global Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2030)
3.4 United States Gene Site-Directed Mutagenesis Services Market Size by Application (2019, 2023 & 2030)
3.5 United States Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2030)
4 Global Gene Site-Directed Mutagenesis Services Competitor Landscape by Company
4.1 Global Gene Site-Directed Mutagenesis Services Market Size by Company
4.1.1 Global Key Companies of Gene Site-Directed Mutagenesis Services, Ranked by Revenue (2023)
4.1.2 Global Gene Site-Directed Mutagenesis Services Revenue by Player (2019-2024)
4.2 Global Gene Site-Directed Mutagenesis Services Concentration Ratio (CR)
4.2.1 Gene Site-Directed Mutagenesis Services Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Site-Directed Mutagenesis Services in 2023
4.2.3 Global Gene Site-Directed Mutagenesis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Gene Site-Directed Mutagenesis Services Head office and Area Served
4.4 Global Key Players of Gene Site-Directed Mutagenesis Services, Product and Application
4.5 Global Key Players of Gene Site-Directed Mutagenesis Services, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Gene Site-Directed Mutagenesis Services Market Size by Company
4.7.1 Key Players of Gene Site-Directed Mutagenesis Services in United States, Ranked by Revenue (2023)
4.7.2 United States Gene Site-Directed Mutagenesis Services Revenue by Players (2022, 2023 & 2024)
5 Global Gene Site-Directed Mutagenesis Services Market Size by Region
5.1 Global Gene Site-Directed Mutagenesis Services Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Gene Site-Directed Mutagenesis Services Market Size by Region (2019-2030)
5.2.1 Global Gene Site-Directed Mutagenesis Services Market Size by Region: 2019-2024
5.2.2 Global Gene Site-Directed Mutagenesis Services Market Size by Region: 2025-2030
6 Americas
6.1 Americas Gene Site-Directed Mutagenesis Services Market Size YoY Growth 2019-2030
6.2 Americas Gene Site-Directed Mutagenesis Services Market Size by Type
6.2.1 Americas Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2024)
6.2.2 Americas Gene Site-Directed Mutagenesis Services Market Size by Type (2025-2030)
6.2.3 Americas Gene Site-Directed Mutagenesis Services Market Share by Type (2019-2030)
6.3 Americas Gene Site-Directed Mutagenesis Services Market Size by Application
6.3.1 Americas Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2024)
6.3.2 Americas Gene Site-Directed Mutagenesis Services Market Size by Application (2025-2030)
6.3.3 Americas Gene Site-Directed Mutagenesis Services Market Share by Application (2019-2030)
6.4 Americas Gene Site-Directed Mutagenesis Services Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Gene Site-Directed Mutagenesis Services Market Size YoY Growth 2019-2030
7.2 EMEA Gene Site-Directed Mutagenesis Services Market Size by Type
7.2.1 EMEA Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2024)
7.2.2 EMEA Gene Site-Directed Mutagenesis Services Market Size by Type (2025-2030)
7.2.3 EMEA Gene Site-Directed Mutagenesis Services Market Share by Type (2019-2030)
7.3 EMEA Gene Site-Directed Mutagenesis Services Market Size by Application
7.3.1 EMEA Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2024)
7.3.2 EMEA Gene Site-Directed Mutagenesis Services Market Size by Application (2025-2030)
7.3.3 EMEA Gene Site-Directed Mutagenesis Services Market Share by Application (2019-2030)
7.4 EMEA Gene Site-Directed Mutagenesis Services Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Gene Site-Directed Mutagenesis Services Market Size by Type
8.1.1 China Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2024)
8.1.2 China Gene Site-Directed Mutagenesis Services Market Size by Type (2025-2030)
8.1.3 China Gene Site-Directed Mutagenesis Services Market Share by Type (2019-2030)
8.2 China Gene Site-Directed Mutagenesis Services Market Size by Application
8.2.1 China Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2024)
8.2.2 China Gene Site-Directed Mutagenesis Services Market Size by Application (2025-2030)
8.2.3 China Gene Site-Directed Mutagenesis Services Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Gene Site-Directed Mutagenesis Services Market Size YoY Growth 2019-2030
9.2 APAC Gene Site-Directed Mutagenesis Services Market Size by Type
9.2.1 APAC Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2024)
9.2.2 APAC Gene Site-Directed Mutagenesis Services Market Size by Type (2025-2030)
9.2.3 APAC Gene Site-Directed Mutagenesis Services Market Share by Type (2019-2030)
9.3 APAC Gene Site-Directed Mutagenesis Services Market Size by Application
9.3.1 APAC Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2024)
9.3.2 APAC Gene Site-Directed Mutagenesis Services Market Size by Application (2025-2030)
9.3.3 APAC Gene Site-Directed Mutagenesis Services Market Share by Application (2019-2030)
9.4 APAC Gene Site-Directed Mutagenesis Services Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 ACGT
10.1.1 ACGT Company Details
10.1.2 ACGT Business Overview
10.1.3 ACGT Gene Site-Directed Mutagenesis Services Introduction
10.1.4 ACGT Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.1.5 ACGT Recent Development
10.2 Azenta Life Sciences
10.2.1 Azenta Life Sciences Company Details
10.2.2 Azenta Life Sciences Business Overview
10.2.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Introduction
10.2.4 Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.2.5 Azenta Life Sciences Recent Development
10.3 Biocompare
10.3.1 Biocompare Company Details
10.3.2 Biocompare Business Overview
10.3.3 Biocompare Gene Site-Directed Mutagenesis Services Introduction
10.3.4 Biocompare Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.3.5 Biocompare Recent Development
10.4 NovoPro Bioscience Inc.
10.4.1 NovoPro Bioscience Inc. Company Details
10.4.2 NovoPro Bioscience Inc. Business Overview
10.4.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Introduction
10.4.4 NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.4.5 NovoPro Bioscience Inc. Recent Development
10.5 Charles River
10.5.1 Charles River Company Details
10.5.2 Charles River Business Overview
10.5.3 Charles River Gene Site-Directed Mutagenesis Services Introduction
10.5.4 Charles River Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.5.5 Charles River Recent Development
10.6 NZYtech
10.6.1 NZYtech Company Details
10.6.2 NZYtech Business Overview
10.6.3 NZYtech Gene Site-Directed Mutagenesis Services Introduction
10.6.4 NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.6.5 NZYtech Recent Development
10.7 Thermofisher
10.7.1 Thermofisher Company Details
10.7.2 Thermofisher Business Overview
10.7.3 Thermofisher Gene Site-Directed Mutagenesis Services Introduction
10.7.4 Thermofisher Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.7.5 Thermofisher Recent Development
10.8 Creatve Biolabs
10.8.1 Creatve Biolabs Company Details
10.8.2 Creatve Biolabs Business Overview
10.8.3 Creatve Biolabs Gene Site-Directed Mutagenesis Services Introduction
10.8.4 Creatve Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.8.5 Creatve Biolabs Recent Development
10.9 Epoch Life Science
10.9.1 Epoch Life Science Company Details
10.9.2 Epoch Life Science Business Overview
10.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Introduction
10.9.4 Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.9.5 Epoch Life Science Recent Development
10.10 GeneToProtein
10.10.1 GeneToProtein Company Details
10.10.2 GeneToProtein Business Overview
10.10.3 GeneToProtein Gene Site-Directed Mutagenesis Services Introduction
10.10.4 GeneToProtein Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.10.5 GeneToProtein Recent Development
10.11 Genewiz
10.11.1 Genewiz Company Details
10.11.2 Genewiz Business Overview
10.11.3 Genewiz Gene Site-Directed Mutagenesis Services Introduction
10.11.4 Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.11.5 Genewiz Recent Development
10.12 GenScript
10.12.1 GenScript Company Details
10.12.2 GenScript Business Overview
10.12.3 GenScript Gene Site-Directed Mutagenesis Services Introduction
10.12.4 GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
10.12.5 GenScript Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ 187 million in 2025 to US$ 269 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-27
Pages: 138
USD 4900.00
(Single User License)
The global Gene Site-Directed Mutagenesis Services market size was US$ 187 million in 2025 and is forecast to reach a readjusted size of US$ 269 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 97
USD 4250.00
(Single User License)
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ 187 million in 2025 and is projected to reach US$ 269 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 120
USD 3950.00
(Single User License)
The global Gene Site-Directed Mutagenesis Services market was valued at US$ 187 million in 2025 and is anticipated to reach US$ 269 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 118
USD 2900.00
(Single User License)
The global Gene Site-Directed Mutagenesis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 97
USD 4250.00
(Single User License)
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 102
USD 3950.00
(Single User License)
The global market for Gene Site-Directed Mutagenesis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 82
USD 2900.00
(Single User License)
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-05-27
Pages: 143
USD 4900.00
(Single User License)
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-05-21
Pages: 114
USD 3950.00
(Single User License)
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ 187 million in 2025 to US$ 269 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-27
Pages: 138
The global Gene Site-Directed Mutagenesis Services market size was US$ 187 million in 2025 and is forecast to reach a readjusted size of US$ 269 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 97
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ 187 million in 2025 and is projected to reach US$ 269 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 120
The global Gene Site-Directed Mutagenesis Services market was valued at US$ 187 million in 2025 and is anticipated to reach US$ 269 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 118
The global Gene Site-Directed Mutagenesis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 97
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 145
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 102
The global market for Gene Site-Directed Mutagenesis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 82
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-05-27
Pages: 143
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-05-21
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now